1,1'-[PROPANE-1,3-DIYLBIS-(BENZENE-1,4-DIYLMETHYLENE)]-BIS-[(4-DIALLYLAMINO)-PYRIDINIUM]-DIBROMIDE
Compound with spectra: 1 NMR
![1,1'-[PROPANE-1,3-DIYLBIS-(BENZENE-1,4-DIYLMETHYLENE)]-BIS-[(4-DIALLYLAMINO)-PYRIDINIUM]-DIBROMIDE](/api/compound/5nre8ShZl5Y.png?ph=true&h=300&w=458 "1,1'-[PROPANE-1,3-DIYLBIS-(BENZENE-1,4-DIYLMETHYLENE)]-BIS-[(4-DIALLYLAMINO)-PYRIDINIUM]-DIBROMIDE")
| SpectraBase Compound ID | 5nre8ShZl5Y |
|---|---|
| InChI | InChI=1S/C39H46N4.2BrH/c1-5-24-42(25-6-2)38-20-28-40(29-21-38)32-36-16-12-34(13-17-36)10-9-11-35-14-18-37(19-15-35)33-41-30-22-39(23-31-41)43(26-7-3)27-8-4;;/h5-8,12-23,28-31H,1-4,9-11,24-27,32-33H2;2*1H/q+2;;/p-2 |
| InChIKey | KAXLCLZQKYRNDO-UHFFFAOYSA-L |
| Mol Weight | 730.633 g/mol |
| Molecular Formula | C39H46Br2N4 |
| Exact Mass | 728.208923 g/mol |
| Parent InChIKey | RUXCTTNRXJIVDM-UHFFFAOYSA-L |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
1,1'-[PROPANE-1,3-DIYLBIS-(BENZENE-1,4-DIYLMETHYLENE)]-[BIS-[4-(1,1-DIHYDROXYETHYL)]-PYRIDINIUM]-DIBROMIDE
1,1'-[METHYLENEBIS-(BENZENE-1,4-DIYLMETHYLENE)]-BIS-[[4-(1,1-DIHYDROXYETHYL)]-ACETYLPYRIDINIUM]-DIBROMIDE
1,1'-[BIPHENYL-4,4'-DIYLBIS-(METHYLENE)]-BIS-(4-ACETYLPYRIDINIUM)-DIBROMIDE
4-benzoyl-1-benzylpyridinium bromide
1-benzyl-4-(dodecylcarbamoyl)pyridinium chloride
4-Phenyl-1-(3-pyridylmethyl)pyridinium tetrafluoroborate
1-(3-oxo-3-phenyl-propenyl)-4-pyrrolidin-1-yl-pyridinium chloride
1-BENZYL-NICOTINAMIDE-BROMIDE
22,25,30-Trioxa-1,19-diazatetracyclo[17.8.5.25,8.212,15]hexatriacont a-3,5,7,12,14,16,33,35-octaene-2,18-dione, (E,E)-
Tricyclo[10.2.2.2(5,8)]octadeca-5,7,12,14,15,17-hexaene, 6-bromo-
| Title | Journal or Book | Year |
|---|---|---|
| Quantitative structure–activity relationships for a series of symmetrical bisquaternary anticancer compounds | Bioorganic & Medicinal Chemistry | 2002 |